| [1] | Yan CHAI, Tao ZHANG, Yinke FAN, Aiwu HUI, Lintao ZHAO, Fang LI, Xiaoli ZHANG. Effect of Yangxue Rougan pills on the TGF-β1/Smad signaling pathway in a rat model of liver fibrosis induced by multiple factors[J]. Journal of Clinical Hepatology, 2022, 38(9): 2040-2045. doi: 10.3969/j.issn.1001-5256.2022.09.018 |
| [2] | Wen QIN, Jianyu YANG, Taiwen CHEN, Haiping ZHENG, Xiaodong ZHU. Expression and significance of L1 cell adhesion molecule and transforming growth factor-β1 in pancreatic cancer tissue[J]. Journal of Clinical Hepatology, 2021, 37(6): 1404-1408. doi: 10.3969/j.issn.1001-5256.2021.06.035 |
| [3] | YUSUFUKADIER·Maimaitinijiati, AIMAITI·Yasen, Li WenDing, Ran Bo, TUERGANAILI.aji, Shao YingMei, Wen Hao. Effect of the transforming growth factor-β1 signaling pathway in inducing the differentiation of hepatic progenitor cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 620-623. doi: 10.3969/j.issn.1001-5256.2020.03.030 |
| [4] | Mo XiaoLi, Liu Jie, Zhu JiaYu, Chen Chuang, Ou Jie, Mao SuFei. Value of transforming growth factor-β1 in diagnosis of primary liver cancer:a meta-analysis[J]. Journal of Clinical Hepatology, 2017, 33(5): 864-868. doi: 10.3969/j.issn.1001-5256.2017.05.014 |
| [5] | An BaiQuan, Xin YongNing, Lu LinLin, Xuan ShiYing. Effect of PNPLA3 I148M mutation on expression of TGF- β1 in rat hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 769-771. doi: 10.3969/j.issn.1001-5256.2016.04.035 |
| [6] | Lei ChengDuo, Li JunFeng, Zheng SuJun, Ren Yan, Zhao Jing, Zhang JingYun, Duan ZhongPing. Diagnostic value of serum apolipoprotein B/A1 ratio for hepatic fibrosis(F≥2) in chronic hepatitis C patients[J]. Journal of Clinical Hepatology, 2015, 31(3): 357-360. doi: 10.3969/j.issn.1001-5256.2015.03.010 |
| [7] | Feng Jie, Tang ZhengHao, Yu YongSheng. Expression of transcription factor Sp1 in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2013, 29(1): 65-67. |
| [8] | Zheng SuJun, Xing XinYue, Wu JuShan, Wang ShiMei, Zhang Ying, Han YuanPing, Yu Hao, Chen Yu, Liu Mei, Duan ZhongPing. ShRNA targeted to rat Smad3 decreases the profibrosis role of TGFβ1 in HSC-T6 cells[J]. Journal of Clinical Hepatology, 2012, 28(4): 289-295. |
| [9] | Gao HuiXia, Liu YuZhen, Lu JianHua, Ye LiHong, Dai ErHei. Correlation of Foxp3 + Tregs and TGFβ1 expression with inflammation in livers of patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(12): 952-955. |
| [10] | Shao XianAn, Yan JiaChun, Gu Min, Ma Yong, Li JunFeng, Xu ZhangJiang. The clinical significance of the analysis of gene amplification and protein expression of α-smooth muscle actin in the liver of patients with CHB[J]. Journal of Clinical Hepatology, 2011, 27(5): 508-510+514. |
| [11] | Li YaPing, Dang ShuangSuo, Zhai Song, Jia XiaoLi, Wang Yuan, Wang XiuFang, Wang WenJun, Li Mei. Immunohistochemical expression of NF-κB, α-SMA and TGFβ1 in experimental hepatic injury rats[J]. Journal of Clinical Hepatology, 2011, 27(11): 1207-1210. |
| [12] | Jiang Ying, A YiTuLa. Expression of TGFβ1、TIMP1 in liver cirrhosis and pathological significance[J]. Journal of Clinical Hepatology, 2009, 25(1): 39-41. |
| [14] | Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62. |
| [15] | Ling YunFeng, Feng ZhenBo, He RuKun, Lu: ZiLi. Expression of TGFβ1、TGFβRⅠ and TGFβRⅡ in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2005, 21(1): 35-37. |
| [16] | Xu TingTing, Jiang MiaoNa, Jia YuJie, Che Ying. Ganfukang's effect on transforming growth factor β1 and laminin of experimental liver fibrosis rats[J]. Journal of Clinical Hepatology, 2005, 21(1): 30-31. |
| [17] | Liu Fang, Li XiuPing, Zhang SuHuan, Li BingShun, Liu JinXing. Influence of serum TGF-β1 on cellular immune function in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(6): 335-337. |
| [18] | Bi Qing, Cheng Lei, Cui LiAn, Zhang JunFu. The effect of Kangxianruanjian on TGF β1 and it's the recepters in liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2002, 18(3): 181-182. |
| [19] | Li QingHua, Li Hui, Qin ChengYong, Han GuoQing. The significance of urine transforming growth factor-β1 (TGF-β1) and serum procollagen type Ⅲ (PCⅢ) , collagen type Ⅳ (Ⅳ-C) , hyaluronic (HA) and laminin (LN) in patient with chronic HBV related liver disease[J]. Journal of Clinical Hepatology, 2001, 17(3): 161-162. |
| [20] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |
DownLoad: